Article Information
History
- July 4, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Lars C. Stene1,*,
- Paz Lopez-Doriga Ruiz1,
- Rickard Ljung2,3,
- Håkon Bøås4,
- Hanne L. Gulseth1,
- Nicklas Pihlström2,3,
- Anders Sundström2,
- Björn Zethelius2,5,
- Ketil Størdal6,7,
- Osman Gani8,9,
- Nicolai A. Lund-Blix8,
- Torild Skrivarhaug7,8 and
- German Tapia1
- 1Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway
- 2Swedish Medical Product Agency; Uppsala, Sweden
- 3Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
- 4Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway
- 5Department of Public Health, Uppsala University, Uppsala, Sweden
- 6Department of Pediatric Research, Oslo University Hospital, Oslo, Norway
- 7Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- 8Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway
- 9Department of Pharmacy, Section for Pharmaceutical Chemistry, University of Oslo, Oslo, Norway
- ↵*Corresponding Author: Lars C. Stene, Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway, P. O. Box 222 Skøyen, NO-0213 Oslo, Norway. E-mail: lars.christian.stene{at}fhi.no